Pfizer Wins Approval for Drug to Treat Type of Leukemia

Pfizer Inc., the world’s largest drugmaker, won U.S. regulatory approval of its treatment for one of the four most common types of leukemia.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.